Chapter 1. Executive Summary
1.1. Market Snapshot
1.2. Global & Segmental Market Estimates & Forecasts, 2018-2027 (USD Billion)
1.2.1. Allergy Immunotherapy Market, by Region, 2018-2027 (USD Billion)
1.2.2. Allergy Immunotherapy Market, by Treatment, 2018-2027 (USD Billion)
1.2.3. Allergy Immunotherapy Market, by Allergy, 2018-2027 (USD Billion)
1.2.4. Allergy Immunotherapy Market, by Distribution Channel, 2018-2027 (USD Billion)
1.3. Key Trends
1.4. Estimation Methodology
1.5. Research Assumption
Chapter 2. Global Allergy Immunotherapy Market Definition and Scope
2.1. Objective of the Study
2.2. Market Definition & Scope
2.2.1. Scope of the Study
2.2.2. Industry Evolution
2.3. Years Considered for the Study
2.4. Currency Conversion Rates
Chapter 3. Global Allergy Immunotherapy Market Dynamics
3.1. Allergy Immunotherapy Market Impact Analysis (2018-2027)
3.1.1. Market Drivers
3.1.2. Market Challenges
3.1.3. Market Opportunities
Chapter 4. Global Allergy Immunotherapy Market Industry Analysis
4.1. Porters 5 Force Model
4.1.1. Bargaining Power of Suppliers
4.1.2. Bargaining Power of Buyers
4.1.3. Threat of New Entrants
4.1.4. Threat of Substitutes
4.1.5. Competitive Rivalry
4.1.6. Futuristic Approach to Porters 5 Force Model (2017-2027)
4.2. PEST Analysis
4.2.1. Political
4.2.2. Economical
4.2.3. Social
4.2.4. Technological
4.3. Investment Adoption Model
4.4. Analyst Recommendation & Conclusion
Chapter 5. Global Allergy Immunotherapy Market, by Treatment
5.1. Market Snapshot
5.2. Global Allergy Immunotherapy Market by Treatment, Performance - Potential Analysis
5.3. Global Allergy Immunotherapy Market Estimates & Forecasts by Treatment 2017-2027 (USD Billion)
5.4. Allergy Immunotherapy Market, Sub Segment Analysis
5.4.1. Subcutaneous Therapy (SCIT)
5.4.2. Sublingual Therapy (SLIT)
Chapter 6. Global Allergy Immunotherapy Market, by Allergy
6.1. Market Snapshot
6.2. Global Allergy Immunotherapy Market by Allergy, Performance - Potential Analysis
6.3. Global Allergy Immunotherapy Market Estimates & Forecasts by Allergy 2017-2027 (USD Billion)
6.4. Allergy Immunotherapy Market, Sub Segment Analysis
6.4.1. Allergic rhinitis
6.4.2. Allergic conjunctivitis
6.4.3. Allergic asthma
6.4.4. Stinging insect venom
6.4.5. Others
Chapter 7. Global Allergy Immunotherapy Market, by Distribution Channel
7.1. Market Snapshot
7.2. Global Allergy Immunotherapy Market by Distribution Channel, Performance - Potential Analysis
7.3. Global Allergy Immunotherapy Market Estimates & Forecasts by Distribution Channel 2017-2027 (USD Billion)
7.4. Allergy Immunotherapy Market, Sub Segment Analysis
7.4.1. Hospitals
7.4.2. E-commerce
7.4.3. Pharmacy
Chapter 8. Global Allergy Immunotherapy Market, Regional Analysis
8.1. Allergy Immunotherapy Market, Regional Market Snapshot
8.2. North America Allergy Immunotherapy Market
8.2.1. U.S. Allergy Immunotherapy Market
8.2.1.1. Treatment breakdown estimates & forecasts, 2017-2027
8.2.1.2. Allergy breakdown estimates & forecasts, 2017-2027
8.2.1.3. Distribution Channel breakdown estimates & forecasts, 2017-2027
8.2.2. Canada Allergy Immunotherapy Market
8.3. Europe Allergy Immunotherapy Market Snapshot
8.3.1. U.K. Allergy Immunotherapy Market
8.3.2. Germany Allergy Immunotherapy Market
8.3.3. France Allergy Immunotherapy Market
8.3.4. Spain Allergy Immunotherapy Market
8.3.5. Italy Allergy Immunotherapy Market
8.3.6. Rest of Europe Allergy Immunotherapy Market
8.4. Asia-Pacific Allergy Immunotherapy Market Snapshot
8.4.1. China Allergy Immunotherapy Market
8.4.2. India Allergy Immunotherapy Market
8.4.3. Japan Allergy Immunotherapy Market
8.4.4. Australia Allergy Immunotherapy Market
8.4.5. South Korea Allergy Immunotherapy Market
8.4.6. Rest of Asia Pacific Allergy Immunotherapy Market
8.5. Latin America Allergy Immunotherapy Market Snapshot
8.5.1. Brazil Allergy Immunotherapy Market
8.5.2. Mexico Allergy Immunotherapy Market
8.6. Rest of The World Allergy Immunotherapy Market

Chapter 9. Competitive Intelligence
9.1. Top Market Strategies
9.2. Company Profiles
9.2.1. ALK
9.2.1.1. Key Information
9.2.1.2. Overview
9.2.1.3. Financial (Subject to Data Availability)
9.2.1.4. Product Summary
9.2.1.5. Recent Developments
9.2.2. Stallergenes Greer
9.2.3. Allergy Therapeutics
9.2.4. Merck KGaA
9.2.5. HAL Allergy B.V.
9.2.6. Biomay AG
9.2.7. Anergis
9.2.8. Aimmune Therapeutics
9.2.9. Circassia
9.2.10. DBV Technologies
Chapter 10. Research Process
10.1. Research Process
10.1.1. Data Mining
10.1.2. Analysis
10.1.3. Market Estimation
10.1.4. Validation
10.1.5. Publishing
10.2. Research Attributes
10.3. Research Assumption